Get complete access to comprehensive company data for Lyrus Life Sciences Private Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Lyrus Life Sciences Private Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 96.25 cr
₹ 96.23 cr
16 Jun 2015
31 Mar 2023
Lyrus Life Sciences Private Limited is an Indian private limited company incorporated on 16 Jun 2015. The company's registered office is situated in Bangaluru, Karnataka, India.
The current status of Lyrus Life Sciences Private Limited is Active. The company has filed its annual returns and financial statements up to 31 Mar 2023 (FY 2022-2023).
Lyrus Life Sciences Private Limited is a company limited by shares with an authorized capital of ₹96.25 cr and a paid-up capital of ₹96.23 cr as per the records maintained by the Ministry of Corporate Affairs (MCA).
Lyrus Life Sciences Private Limited has 2 directors and 1 signatories. The Key Managerial Personnel (KMP) at Lyrus Life Sciences Private Limited include Dasari Ramesh as Company Secretary. The directors of the company include Hemanth Kumar Bothra, Leela Kanwar.
The registered office of Lyrus Life Sciences Private Limited is located at No.22, 7Th Cross, Jaibharath Nagar Bangalore Karnataka 560033 India in Bangaluru, Karnataka, India.
- CIN/LLPIN/FCRN: U24230KA2015PTC080902
- Legal Name: Lyrus Life Sciences Private Limited
- ROC Code: Roc Bangalore
- Company No.: 080902
- Company Category: Company Limited By Shares
- Company Sub Category: Non-Government Company
- Company Class: Private
- Listing Status: Unlisted
- Industry: -
- Date of AGM: 30 Sep 2023
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Lyrus Life Sciences Private Limited |
|---|
Frequently Asked Questions
- dasari ramesh
- hemanth kumar bothra
- leela kanwar